|
|
|
|
| LEADER |
01387nam a2200313 u 4500 |
| 001 |
EB001853630 |
| 003 |
EBX01000000000000001017933 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
181108 r ||| eng |
| 020 |
|
|
|a 9789283212768
|
| 020 |
|
|
|a 9283212762
|
| 245 |
0 |
0 |
|a Some antiviral and antineoplastic drugs, and other pharmaceutical agents
|h Elektronische Ressource
|
| 260 |
|
|
|a Lyon, France
|b IARC
|c 2000, 2000
|
| 300 |
|
|
|a iv, 521 p.
|c 24 cm
|
| 505 |
0 |
|
|a Includes bibliographic references and index
|
| 653 |
|
|
|a Antineoplastic Agents / adverse effects
|
| 653 |
|
|
|a Phenolphthalein / adverse effects
|
| 653 |
|
|
|a Carcinogens
|
| 653 |
|
|
|a Vitamin K / adverse effects
|
| 653 |
|
|
|a Antiviral Agents / adverse effects
|
| 710 |
2 |
|
|a IARC Working Group on the Evaluation of Carcinogenic Risks to Humans
|
| 710 |
2 |
|
|a International Agency for Research on Cancer
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a IARC monographs on the evaluation of carcinogenic risks to humans
|
| 500 |
|
|
|a "This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 12-19 October 1999."
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK401398
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|